Sun Pharmaceutical Industries
₹1,810.00
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- ₹4.34T
- Enterprise value
- ₹3.87T
- P/E (trailing 12 months)
- 39.8
- Forward P/E
- 32.0
- Price/book
- 5.58
- Price/sales
- 7.64
- EV/EBITDA
- 24.2
- EV/revenue
- 6.82
Profitability and growth
- Gross margin
- 78.5%
- Operating margin
- 26.2%
- Net margin
- 19.2%
- Revenue growth (year over year)
- 13.5%
- Earnings growth (year over year)
- 15.7%
Financial health
- Total cash
- ₹278.8B
- Total debt
- ₹52.15B
- Debt/equity
- 0.07
Dividends
- Annual dividend per share
- ₹16.50
- Dividend yield
- 1.0%
- Payout ratio
- 35.2%
- Ex-dividend date
- February 5, 2026
Analysts and estimates
- Average price target
- ₹1,963.26
- Median price target
- ₹1,984.00
- High price target
- ₹2,450.00
- Low price target
- ₹1,550.00
- Analysts with a price target
- 38
- Consensus
- Buy
- Forward EPS
- ₹56.55
- EPS estimate, current year
- ₹50.35
Shares and trading
- Beta
- 0.10
- Average volume
- 127.91K
- Shares outstanding
- 2.4B
- Float
- 1.07B
- Institutional ownership
- 27.4%
- Insider ownership
- 55.6%